Market Overview:
The global uveal melanoma treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of uveal melanoma, rising awareness about uveal melanoma and its treatment options, and technological advancements in the field of ophthalmology. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global uveal melanoma treatment market can be segmented into ciliary melanoma, iris melanoma, and choroid melanoma. Based on application, the market can be divided into hospitals, ophthalmology clinics, and others (including research institutes and academic centers). Geographically speaking, North America dominates this market followed by Europe due to better reimbursement scenario for medical treatments in these regions as compared to other regions such as Asia Pacific or Latin America.
Product Definition:
Uveal melanoma is a cancer that starts in the cells that form the uvea, which is the middle layer of the eye. Treatment for uveal melanoma may include surgery to remove the tumor, radiation therapy, or chemotherapy.
Ciliary Melanoma:
Ciliary melanoma is a rare type of uveal melanoma. It accounts for 1% of all the malignant tumors in the eye and has a 5-year survival rate. The condition may develop at any age but mostly affects people in their 50s or 60s. Ciliary melanoa is most common in people with blue eyes, although it can occur in any race or gender.
Iris Melanoma:
Iris melanoma is a type of skin cancer that begins in the iris (the colored part) of the eye. It is also known as a blue or hazel eye. The color can vary from one individual to another and may look like green, yellow, or blue-gray on an affected person's skin.
Application Insights:
Based on application, the global uveal melanoma treatment market is segmented into hospitals, ophthalmology clinics and others. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities and a large number of patients suffering from eye cancer. Moreover, increasing awareness about uveal melanoma among hospital professionals plays a key role in driving growth.
Ophthalmology clinics are expected to witness lucrative growth over the forecast period due to increasing incidence rates of eye cancer coupled with rising adoption of ciliary and iris melanomas as primary tumors for diagnosis. Growing preference for these types of tumor compared to other locations such as brain or lungs also boosts demand globally. Furthermore, these types of tumors have high cure rates which encourages clinicians across the globe to recommend them over other treatments when diagnosed in early stages at ophthalmic settings which further drives demand globally during this period (upcoming years).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for advanced treatment options, and favorable reimbursement policies. In addition, increasing cases of uveal melanoma are expected to drive regional growth over the forecast period. For instance, as per American Cancer Society (ACS), in 2018 more than 1 million people will be diagnosed with cancer in U.S., and it is estimated that about 795,000 people will die due to this disease during same year (ACS).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments & private agencies coupled with growing awareness among patients regarding various treatment options available for uveal melanoma.
Growth Factors:
- Increasing incidence of uveal melanoma
- Growing awareness about uveal melanoma and its treatment options
- Rising demand for better and innovative treatments for uveal melanoma
- Availability of government funding for research on uveal melanoma treatment
- Technological advancements in the field of uveal melanoma treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Uveal Melanoma Treatment Market Research Report
By Type
Ciliary Melanoma, Iris Melanoma, Choroid Melanoma
By Application
Hospitals, Ophthalmology Clinics, Others
By Companies
Eli Lilly & Co., Spectrum Pharmaceuticals, Inc., Novartis AG, Bayer, Astra Zeneca plc, Merck, Amgen, Pfizer, Inc., Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Uveal Melanoma Treatment Market Report Segments:
The global Uveal Melanoma Treatment market is segmented on the basis of:
Types
Ciliary Melanoma, Iris Melanoma, Choroid Melanoma
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ophthalmology Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly & Co.
- Spectrum Pharmaceuticals, Inc.
- Novartis AG
- Bayer
- Astra Zeneca plc
- Merck
- Amgen
- Pfizer, Inc.
- Roche
Highlights of The Uveal Melanoma Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ciliary Melanoma
- Iris Melanoma
- Choroid Melanoma
- By Application:
- Hospitals
- Ophthalmology Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Uveal Melanoma Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for uveal melanoma will vary depending on the individualu2019s specific situation and health history. However, some common treatments for uveal melanoma include surgery, radiation therapy, and chemotherapy.
Some of the key players operating in the uveal melanoma treatment market are Eli Lilly & Co., Spectrum Pharmaceuticals, Inc., Novartis AG, Bayer, Astra Zeneca plc, Merck, Amgen, Pfizer, Inc., Roche.
The uveal melanoma treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Uveal Melanoma Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Uveal Melanoma Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Uveal Melanoma Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Uveal Melanoma Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Uveal Melanoma Treatment Market Size & Forecast, 2018-2028
4.5.1 Uveal Melanoma Treatment Market Size and Y-o-Y Growth
4.5.2 Uveal Melanoma Treatment Market Absolute $ Opportunity
Chapter 5 Global Uveal Melanoma Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Uveal Melanoma Treatment Market Size Forecast by Type
5.2.1 Ciliary Melanoma
5.2.2 Iris Melanoma
5.2.3 Choroid Melanoma
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Uveal Melanoma Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Uveal Melanoma Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ophthalmology Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Uveal Melanoma Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Uveal Melanoma Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Uveal Melanoma Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Uveal Melanoma Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Uveal Melanoma Treatment Market Size Forecast by Type
9.6.1 Ciliary Melanoma
9.6.2 Iris Melanoma
9.6.3 Choroid Melanoma
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Uveal Melanoma Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ophthalmology Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Uveal Melanoma Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Uveal Melanoma Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Uveal Melanoma Treatment Market Size Forecast by Type
10.6.1 Ciliary Melanoma
10.6.2 Iris Melanoma
10.6.3 Choroid Melanoma
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Uveal Melanoma Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ophthalmology Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Uveal Melanoma Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Uveal Melanoma Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Uveal Melanoma Treatment Market Size Forecast by Type
11.6.1 Ciliary Melanoma
11.6.2 Iris Melanoma
11.6.3 Choroid Melanoma
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Uveal Melanoma Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ophthalmology Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Uveal Melanoma Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Uveal Melanoma Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Uveal Melanoma Treatment Market Size Forecast by Type
12.6.1 Ciliary Melanoma
12.6.2 Iris Melanoma
12.6.3 Choroid Melanoma
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Uveal Melanoma Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ophthalmology Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Uveal Melanoma Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Uveal Melanoma Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Uveal Melanoma Treatment Market Size Forecast by Type
13.6.1 Ciliary Melanoma
13.6.2 Iris Melanoma
13.6.3 Choroid Melanoma
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Uveal Melanoma Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ophthalmology Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Uveal Melanoma Treatment Market: Competitive Dashboard
14.2 Global Uveal Melanoma Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eli Lilly & Co.
14.3.2 Spectrum Pharmaceuticals, Inc.
14.3.3 Novartis AG
14.3.4 Bayer
14.3.5 Astra Zeneca plc
14.3.6 Merck
14.3.7 Amgen
14.3.8 Pfizer, Inc.
14.3.9 Roche
